We found that in terms of metabolic parameters, additional upregulation of the anti-oxidative stress response further improved NAFLD outcome in terms of metabolic changes in L-selectin-deficient mice. The gene discussed is SELL; the disease is metabolic dysfunction-associated steatotic liver disease.